Alliance Pharma PLC, an international healthcare group, has announced its total voting rights as of 30 September 2023. The company's issued share capital consists of 540,164,462 Ordinary Shares of 1p each, and the total number of voting rights in the company is also 540,164,462. Shareholders can use this figure as the denominator for calculating their interest in the company under the FCA's Disclosure Guidance and Transparency Rules. Alliance Pharma aims to empower people to improve their health and wellbeing by making its trusted brands available worldwide. The company achieves organic growth through investing in priority brands and channels, innovation, and selective geographic expansion. It may also consider complementary acquisitions to enhance organic growth.